Nasal Delivery Devices Market – By Drug Type (Anesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, and Antihistamines); By Technologies (Spray, Nebulizers, and Inhalers); By End-User (Home Care, Settings, Hospitals, and Clinics), and by Region¬–Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2020-2026

Published Date: 04-May-2021 Category: Medical Device Report Format : PDF Pages: 142 Report Code: ZMR-6205 Status : Published

The global Nasal Delivery Devices Market, which was estimated at 57.1(USD Billion) in 2019 and is anticipated to accrue earnings worth 80.1(USD Billion) by 2026, is set to record a CAGR of nearly 6.1% over 2020-2026.

Description

The global Nasal Delivery Devices Market, which was estimated at 57.1(USD Billion) in 2019 and is anticipated to accrue earnings worth 80.1(USD Billion) by 2026, is set to record a CAGR of nearly 6.1% over 2020-2026. The report offers valuation and analysis of Nasal Delivery Devices market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2019 along with a forecast from 2020 to 2026 based on value (USD Billion).

Introduction

Nasal delivery is the rational choice for topical treatment of nose & paranasal sinuses including allergic & non-allergic rhinitis as well as sinusitis. Apart from this, nose is a key path for systemic medicine delivery and needle-free vaccination. Moreover, nasal delivery equipment addresses concerns pertaining to slow absorption, adverse activities in gastrointestinal tract, poor bioavailability, prevents first-pass metabolism in liver, drug degradation, and slow absorption. Apparently, nasal delivery device is highly popular drug delivery route among the healthcare service providers & patients.

Nasal Delivery Devices Market: Growth Drivers

The growth of nasal delivery devices industry over the forecast period can be attributed to its non-invasive features and huge medicine absorption through nasal route. Apart from this, easy administration of the medicines in the patient has played a key role in enhancing the compliance of drug treatments in patients, thereby driving the market trends. Furthermore, surge in the cases of brain disorders is anticipated to enhance the demand for nasal delivery devices. In addition to this, many of the scientific research papers have supported the use of drug delivery through nasal equipment as the latter facilitates high permeability of medicines through blood brain drainer. This, in turn, will steer the business growth over the forecast timeline. In addition to this, the escalating occurrence of respiratory ailments as well as neurological diseases will boost the use of nasal delivery devices industry.

Regional Landscape

North American Market To Steer Nasal Delivery Devices Market Size By 2026

The expansion of nasal delivery devices industry over 2020-2026 can be credited to rise in the number of CNS tumors among the children aged between 0 to 14. Surge in the respiratory tract infections, TB, COPD, lung cancer, and asthma in the region will prompt the market growth in the sub-continent in the years to come. Unhealthy lifestyle, high tobacco inhalation, and growing pollution due to urbanization & industrialization in U.S. and Canada will culminate into massive regional market surge over 2020-2026.

Competitive Landscape

Key players profiled in the report include Novartis AG; GlaxoSmithKline plc.; Merck & Co. Inc.; AstraZeneca; Pfizer Inc.; BD; Dr. Reddy's Laboratories; Sanofi; Cadila Pharmaceuticals Ltd.; and Neurelis, Inc.

The global Nasal Delivery Devices Market is segmented as follows:

By Drug Type

  • Anesthetics
  •  Antibiotics
  •  Pain Relief Drugs
  •  Calcium Supplements
  •  Vasoconstrictors
  •  Antihistamines
  •  Others

By Technologies

  • Spray
  • Nebulizers
  • Inhalers

By End User

  • Home Care
  • Settings
  • Hospitals
  • Clinics

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Nasal Delivery Devices Market, 2016–2026 (USD Billion)
    • 2.2. Nasal Delivery Devices Market: Snapshot
  • Chapter 3. Global Nasal Delivery Devices Market– Industry Analysis
    • 3.1. Nasal Delivery Devices Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. The growth of nasal delivery devices industry over the forecast period can be attributed to its non-invasive features and huge medicine absorption through nasal route.
      • 3.2.2. Easy administration of the medicines in the patient has played a key rule in enhancing the compliance of drug treatments in patients, thereby driving the market trends.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Drug Type
      • 3.4.2. Market attractiveness analysis By Technulogies
      • 3.4.3. Market attractiveness analysis By End-User
  • Chapter 4. Global Nasal Delivery Devices Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Nasal Delivery Devices Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Nasal Delivery Devices Market– Drug Type Analysis
    • 5.1. Global Nasal Delivery Devices Market overview: By Drug Type
      • 5.1.1. Global Nasal Delivery Devices Market share, By Drug Type , 2019 and 2026
    • 5.2. Anesthetics
      • 5.2.1. Global Nasal Delivery Devices Market By Anesthetics, 2016–2026 (USD Billion)
    • 5.3. Antibiotics
      • 5.3.1. Global Nasal Delivery Devices Market By Antibiotics, 2016–2026 (USD Billion)
    • 5.4. Pain Relief Drugs
      • 5.4.1. Global Nasal Delivery Devices Market By Pain Relief Drugs, 2016–2026 (USD Billion)
    • 5.5. Calcium Supplements
      • 5.5.1. Global Nasal Delivery Devices Market By Calcium Supplements, 2016–2026 (USD Billion)
    • 5.6. Vasoconstrictors
      • 5.6.1. Global Nasal Delivery Devices Market By Vasoconstrictors, 2016–2026 (USD Billion)
    • 5.7. Antihistamines
      • 5.7.1. Global Nasal Delivery Devices Market By Antihistamines, 2016–2026 (USD Billion)
  • Chapter 6. Global Nasal Delivery Devices Market– Technulogies Analysis
    • 6.1. Global Nasal Delivery Devices Market overview: By Technulogies
      • 6.1.1. Global Nasal Delivery Devices Market share, By Technulogies , 2019 and 2026
    • 6.2. Spray
      • 6.2.1. Global Nasal Delivery Devices Market By Spray, 2016–2026 (USD Billion)
    • 6.3. Nebulizers
      • 6.3.1. Global Nasal Delivery Devices Market By Nebulizers, 2016–2026 (USD Billion)
    • 6.4. Inhalers
      • 6.4.1. Global Nasal Delivery Devices Market By Inhalers, 2016–2026 (USD Billion)
  • Chapter 7. Global Nasal Delivery Devices Market– End-User Analysis
    • 7.1. Global Nasal Delivery Devices Market overview: By End User
      • 7.1.1. Global Nasal Delivery Devices Market share, By End User, 2019 and 2026
    • 7.2. Home Care
      • 7.2.1. Global Nasal Delivery Devices Market By Home Care, 2016–2026 (USD Billion)
    • 7.3. Settings
      • 7.3.1. Global Nasal Delivery Devices Market By Settings, 2016–2026 (USD Billion)
    • 7.4. Hospitals
      • 7.4.1. Global Nasal Delivery Devices Market By Hospitals, 2016–2026 (USD Billion)
    • 7.5. Clinics
      • 7.5.1. Global Nasal Delivery Devices Market By Clinics, 2016–2026 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. J. Novartis AG
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfulio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. GlaxoSmithKline plc
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfulio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Merck & Co. Inc.
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfulio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. AstraZeneca
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfulio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Pfizer Inc.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfulio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. BD
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfulio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Dr. Reddy's Laboratories
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfulio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. Sanofi
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfulio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. Cadila Pharmaceuticals Ltd.
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfulio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development
    • 8.10. Neurelis, Inc.
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfulio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development

Methodology


Frequently Asked Questions

The growth of nasal delivery devices industry over the forecast period can be attributed to its non-invasive features and huge medicine absorption through nasal route. Apart from this, easy administration of the medicines in the patient has played a key role in enhancing the compliance of drug treatments in patients, thereby driving the market trends. Furthermore, surge in the cases of brain disorders is anticipated to enhance the demand for nasal delivery devices. In addition to this, many of the scientific research papers have supported the use of drug delivery through nasal equipment as the latter facilitates high permeability of medicines through blood brain drainer. This, in turn, will steer the business growth over the forecast timeline. In addition to this, the escalating occurrence of respiratory ailments as well as neurological diseases will boost the use of nasal delivery devices industry.

According to Zion Market Research report, the global Nasal Delivery Devices Market, which was estimated at 57.1(USD Billion) in 2019 and is anticipated to accrue earnings worth 80.1(USD Billion) by 2026, is set to record a CAGR of nearly 6.1% over 2020-2026.

North America is likely to make noteworthy contributions towards overall market revenue. The growth of the industry in the sub-continent over the estimated timespan is attributed to rise in the number of CNS tumors among the children aged between 0 to 14. Surge in the respiratory tract infections, TB, COPD, lung cancer, and asthma in the region will prompt the market growth in the sub-continent in the years to come. Unhealthy lifestyle, high tobacco inhalation, and growing pollution due to urbanization & industrialization in U.S. and Canada will culminate into massive regional market surge over 2020-2026.

The key players profiled in the report include are Novartis AG; GlaxoSmithKline plc.; Merck & Co. Inc.; AstraZeneca; Pfizer Inc.; BD; Dr. Reddy's Laboratories; Sanofi; Cadila Pharmaceuticals Ltd.; and Neurelis, Inc.
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com